RxDoctor Payments DataLook up a doctor →

William Muller

Pediatric Infectious Diseases · Chicago, ILNPI 1790896041

Payments from drug & device makers

$5,917,676in general payments, 2019–2025

Across 726 payments — averaging $8151.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$3.8M
  • AstraZeneca$474K
  • Astellas Pharma Global Development$354K
  • Abbott$292K
  • Astrazeneca UK Limited$290K
  • Merck$250K
  • plus $484K from 12 others
$9,749in research payments, 2019–2025

Across 33 payments — averaging $295.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Astellas US Technologies$6K
  • Astellas Pharma Global Development$4K

What the payments were for

  • Consulting fees$42,22974%
  • Speaking & faculty fees$2,0004%
  • Travel & lodging$11,32920%
  • Food & beverage$1,3472%

General payments by program year

19
20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,917,676 in reported general payments places this provider in the 95th percentile of 29 pediatric infectious diseases providers in Illinois.

See all pediatric infectious diseases providers in Illinois

Other pediatric infectious diseases in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →